✦ LIBER ✦

Yttrium-90–ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin's lymphoma

✍ Scribed by Avichai Shimoni; S. Tzila Zwas; Yakov Oksman; Izhar Hardan; Noga Shem-Tov; Ronit Yerushalmi; Abraham Avigdor; Isaac Ben-Bassat; Arnon Nagler

Book ID: 113616316
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 186 KB
Volume: 35
Category: Article
ISSN: 0301-472X
DOI: 10.1016/j.exphem.2007.01.043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized study comparing yttrium-90

A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma

✍ Avichai Shimoni; Irit Avivi; Jacob M. Rowe; Moshe Yeshurun; Itai Levi; Reuven Or 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB

Ibritumomab tiuxetan (Zevalin) in the co

Ibritumomab tiuxetan (Zevalin) in the conditioning regimen for autologous and reduced-intensity allogeneic stem-cell transplantation (SCT) in patients with chemo-refractory non-hodgkin’s lymphoma

✍ A. Shimoni; T. Zwass; Y. Oksman; I. Hardan; N. Shem-Tov; R. Yerushalmi; A. Avigd 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Improving survival in patients with tran

Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with 90Yttrium ibritumomab tiuxetan-BEAM and autologous stem cell transplantation

✍ Marielle J. Wondergem; Josee M. Zijlstra; Madelon de Rooij; Otto J. Visser; Pete 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

The city of hope experience with novel t

The city of hope experience with novel transplant regimens that incorporate standard and escalated dose 90YTTRIUM ibritumomab tiuxetan (90Y-Zevalin®) radioimmunotherapy (RIT) for autologous stem cell transplantation (ASCT) in patients with B-cell non-Hodgkin’s lymphoma (NHL): targeted intensification without increased toxicity and elimination of total body irradiation (TBI)

✍ A. Nademanee; H. Fung; A. Molina; A. Krishnan; R. Rodriguez; L. Popplewell; R.T. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Feasibility and Efficacy of High-Dose Me

Feasibility and Efficacy of High-Dose Melphalan, Cyclophosphamide, Etoposide, and Dexamethasone (LEED) Chemotherapy with or without Rituximab Followed by Autologous Stem Cell Transplantation for Aggressive and Relapsed Non-Hodgkin’s Lymphoma

✍ Li-na Han; Jin Zhou; Takayuki Hirose; Yosuke Imai; Takuro Ishiguro; Takaaki Chou 📂 Article 📅 2006 🏛 Carden Jennings Publishing 🌐 English ⚖ 137 KB

Pre-transplant positron emission tomogra

Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin’s lymphoma

✍ Cremerius, U; Fabry, U; Wildberger, J E; Zimny, M; Reinartz, P; Nowak, B; Schaef 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 178 KB